Telangana: At least five dead, several injured after chemical reactor blast at pharma plant
At least five persons were killed and 20 others were injured on Monday after an explosion at a chemical reactor unit triggered a fire at a pharmaceutical company near Hyderabad, The Hindu reported.
The blast took place at Sigachi Industries Private Limited, located in the Pashamylaram industrial area.
The fire caused part of the building to collapse, trapping workers under the debris.
The explosion was reported to the fire control room at 9.37 am, The Hindu reported.
Emergency teams, including 11 fire department vehicles, were deployed to the scene. Efforts are underway to locate any remaining trapped persons, The Hindu reported.
Fire department officials said all the injured workers have been taken to hospitals in the vicinity.
A major reactor blast at Sigachi, a chemical unit in Pasamailaram, Patancheru, left several feared dead and many seriously injured. The injured have been shifted to hospital as fire and medical teams continue rescue efforts. @NewIndianXpress pic.twitter.com/J5g4DWchM1
— TNIE Telangana (@XpressHyderabad) June 30, 2025
According to a preliminary assessment, the blast may have been caused by a pressure buildup inside a reactor at the pharmaceutical manufacturing plant, The Hindu reported. A detailed investigation has been launched to determine the exact cause of the incident and to assess whether safety norms were followed.
Telangana Chief Minister Revanth Reddy told officials to ensure that the injured persons receive appropriate medical treatment, and said that the government was committed to supporting the affected families.
Sigachi Industries specialises in pharma excipients, nutraceuticals, cosmetics, and food ingredients. Following the blast, the company's stock on the Bombay Stock Exchange fell sharply by over 9%, trading at Rs 47.89 by 1 pm.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
33 minutes ago
- Time of India
Apollo Hospitals to hive-off pharmacy, digital health businesses
Apollo Hospitals Enterprise on Monday said its board has approved separate listing of its omnichannel pharmacy and digital health businesses within 18-21 months, as part of reorganisation exercise to unlock value. The board of directors of Apollo Hospitals and Apollo HealthCo, a subsidiary of the the healthcare major, have accorded in-principle approval for the composite scheme of arrangement. The scheme entails the demerger of the Omni Channel Pharma and Digital Health business -- comprising the telehealth business of Apollo and its investment in AHL (Apollo HealthCo Limited) -- into a new entity. Following the demerger, the scheme provides for the amalgamation of AHL with the new entity. It would subsequently be followed by the amalgamation of Keimed Pvt Ltd , India's leading wholesale pharmaceutical distributor, with NewCo (new entity). Live Events The scheme creates a formidable omnichannel pharmacy distribution and digital health platform leader in India, with stated plans to achieve Rs 25,000 crore revenue by FY27, Apollo Hospitals Enterprise said in a regulatory filing. Upon the effectiveness of the Scheme, the new entity will become an Indian Owned and Controlled Company (IOCC) and will apply for listing on the stock exchanges, it added. The listing is expected within 18-21 months, the healthcare major said. Upon becoming an IOCC, the entity also proposes to consolidate the front-end pharmacy business by acquiring the remaining 74.5 per cent stake in Apollo Medicals Pvt Ltd (AMPL), which owns 100 per cent of Apollo Pharmacies Limited (APL), it said. Apollo Hospitals Enterprise Ltd (AHEL) will retain 15 per cent stake in the 'NewCo' to ensure an integrated, seamless, and comprehensive healthcare offering across the patient lifecycle, it added. "The omnichannel pharmacy business and integrated digital healthcare ecosystem will be a unique model to enable access to high-quality healthcare for millions of Indians," Apollo Hospitals Group Chairman Prathap C Reddy said. Apollo Hospitals Enterprise MD Suneeta Reddy said the proposal enables the healthcare provider's shareholders to gain direct shareholding to country's largest omni-channel pharmacy and digital health platform. "The new entity, once integrated, will be a truly customer-focused healthcare leader, with capabilities across the value chain. Delivering medicines seamlessly from 7000+ physical stores, online delivery platform serving over 19,000 pincodes, with Keimed ensuring supply chain integrity, our aspiration is that we will serve over 100 million Indians," Apollo HealthCo Executive Chairperson Shobana Kamineni said. Shares of Apollo Hospitals Enterprise ended 0.87 per cent down at Rs 7,242.75 apiece on BSE. Economic Times WhatsApp channel )
Time of India
an hour ago
- Time of India
Telangana factory blast: Rescue teams unsure of survivors under debris; DNA tests under way to identify charred bodies
NEW DELHI: After the deadly explosion at Pharma factory in Telangana's Sangareddy district on Monday, rescue officials said they remain unsure about how many individuals are still trapped under the debris of the collapsed factory building. Blast during drying process; fire followed 'Today, at around 9.48 am, there was a blast in the drying unit at Sigachi Pharma Company. The explosion led to a fire. A total of 12 people have died and 35 are injured in the incident,' said Y Nagi Reddy, Director General of the Telangana State Disaster Response and Fire Services, as quoted by ANI. He said the blast likely occurred during the air handling or drying of microcrystalline cellulose, a compound used in pharmaceuticals. 'We are currently unsure of the number of people under the debris,' Reddy added. The explosion, which took place at Pashamylaram industrial area, about 50 km from Hyderabad, caused significant structural damage. Inspector General of Police V Satyanarayana said the impact was felt across a 5 km radius. Rescue ops underway; charred bodies await DNA profiling Rescue operations are being carried out by multiple teams, including the National Disaster Response Force (NDRF). by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Trending in in 2025: Local network access control [Click Here] Esseps Learn More Undo Authorities said at least half a dozen bodies were burnt beyond recognition, and DNA tests are underway to establish their identities. 'A few bodies are burnt beyond recognition, and DNA profiling is underway to establish their identities,' said a Revenue Department official. State ministers visit site; 12 critical among injured Telangana Labour Minister G Vivek Venkatswamy and Health Minister C Damodar Raja Narasimha visited the accident site and hospitals treating the injured. Venkatswamy told reporters that out of the 34 injured, 12 are in critical condition and on ventilator support. The factory incharge was among those killed. 'Nearly 63 people reported for work this morning. Initially, it was thought to be a reactor blast, but later we found it was in the drying unit,' he said. 'There is no one from the factory to explain what exactly happened,' the minister added. PM Modi, CM Revanth Reddy express grief Prime Minister Narendra Modi offered condolences and announced compensation. 'An ex-gratia of Rs 2 lakh would be given to the next of kin of each deceased, and Rs 50,000 to the injured,' the PMO posted on X. Chief minister A Revanth Reddy expressed anguish and directed officials to prioritise rescue and provide advanced medical aid. He also instructed a thorough investigation into the cause. Company issues statement of condolence In a statement, Sigachi Pharma said, 'Sigachi deeply mourns the loss of lives and extends heartfelt condolences to the families of the deceased. We are extending all possible support to the affected.' According to the company's website, Sigachi Industries is engaged in the production of Active Pharmaceutical Ingredients (APIs), excipients, mineral blends, and other pharma-related services. Cause not yet confirmed; forensic probe underway The precise cause of the blast is yet to be determined. 'Industrial experts suspect pressure build-up during drying or handling of materials caused the explosion, which destroyed both the unit and parts of the industrial building,' Reddy told PTI. Officials said more clarity is expected after a technical and forensic evaluation. In the meantime, the government has promised interim financial aid for the victims and their families.
Time of India
an hour ago
- Time of India
Apollo Hospitals approves major restructuring plans; to list digital health, pharmacy arms
Apollo Hospitals Enterprise Limited's ( AHEL ) board on Monday announced a sweeping corporate overhaul, approving a composite scheme of arrangement involving its subsidiaries Apollo Healthco Limited (AHL) and Keimed Private Limited, alongside its wholly owned subsidiary Apollo Healthtech Limited. Under the restructuring exercise, the company will first demerge its 'Identified Business Undertaking' into Apollo Healthtech. Subsequently, both AHL and Keimed Private Limited will be merged into Apollo Healthtech, consolidating critical operations under one roof. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like My baby is in so much pain, please help us? Donate For Health Donate Now Undo Through this move, AHEL aims to unlock value through strategic reorganisation, enabling direct listing of its Omni Channel Pharmacy and Digital Health business, a company filing to the exchanges said. "Composite Scheme creates a formidable Omni Channel Pharmacy Distribution and Digital Health platform leader in India, with scale of Rs 16,300 crores (US$1.9bn) of revenue in FY25, with stated plans to achieve Rs 25,000 crores revenue by FY27, with 7% EBITDA margin," the company filing added. Following this transaction, Apollo Healthtech Limited will seek listing of its equity shares on the NSE and BSE, paving the way for investors to participate directly in the reorganised entity. Live Events Additionally, Apollo disclosed an agreement signed on June 30, 2025, between Rasmeli Limited, an existing shareholder of AHL, and AHL promoter Shobana Kamineni. Rasmeli agreed to share a portion of its investment upside with the promoter and key employees, aligning interests and rewarding performance. AHEL shareholders to have direct shareholding in a combined entity. For every 100 shares of AHEL, AHEL shareholders will receive 195.2 shares of the new entity. Listing of the entity is expected in 18-21 months, the company filing said. Commenting on the development, Suneeta Reddy, Managing Director, Apollo Hospitals Enterprise, said, "This comprehensive integrated network, overlaid with a strong digital layer, will allow us to create an impact of magnitude greater than could be achieved with a single format of care. This proposal enables AHEL shareholders to gain direct shareholding in India's largest Omni-Channel Pharmacy and Digital Health Platform, enabling full value discovery and eliminating any hold co discount in valuation. Meanwhile, AHEL will continue its focus on healthcare delivery, she added.
